Cholesterol: Why Your Total Number Tells You Almost Nothing

You get your blood work back. Your total cholesterol is 220. Your GP says it's high. You need a statin. Or you're relieved because it's below 200, which means you're safe.

That total number? It's almost meaningless for predicting your actual heart disease risk. Yet it's the number almost every doctor focuses on. This is one of the most consequential misunderstandings in modern healthcare, and it's costing people money, side effects, and false reassurance.

Your total cholesterol tells you nothing about what matters. It's like knowing the average age of people in a room without knowing whether it's full of children and pensioners or all young adults. The composition is everything.

LDL particle size: why you can't judge cholesterol by its number

Not all LDL cholesterol is created equal. Your LDL comes in different sizes, and size matters enormously for whether it damages your arteries.

Large, buoyant LDL particles are relatively benign. They don't penetrate the arterial wall effectively and they're cleared from your bloodstream efficiently. Small, dense LDL particles, on the other hand, are the dangerous ones. They're sticky. They penetrate deep into the arterial lining. They oxidise more easily. They trigger inflammation. They're the ones that actually build plaques and cause heart attacks.

A landmark 2010 study in the Journal of the American College of Cardiology (Krauss et al.) examined the relationship between LDL particle size and coronary heart disease risk. The finding was decisive: people with predominantly small, dense LDL particles had a threefold increased risk of coronary disease compared to those with predominantly large, buoyant LDL. The actual LDL cholesterol number didn't matter much. The particle size was what predicted disease.

Here's the problem: standard lipid panels don't measure particle size. You could have high total cholesterol, high LDL cholesterol, but if it's all large, buoyant particles, you're probably fine. Or you could have normal LDL cholesterol on a standard test but mostly small, dense particles, and your risk is actually high. The number is lying to you in both directions.

ApoB is the real number you should be tracking

ApoB (apolipoprotein B) is the protein that wraps around LDL, VLDL, and other atherogenic particles. Every single one of these particles has exactly one ApoB molecule. That means counting ApoB particles tells you how many atherogenic particles are actually in your blood.

A comprehensive meta-analysis by Sniderman and colleagues found that ApoB is a stronger predictor of cardiovascular disease than LDL cholesterol alone. More important: when ApoB and LDL disagree (someone has high LDL but normal ApoB, or vice versa), ApoB is the better predictor of actual risk. Multiple studies show that people with discordant values, high LDL but low ApoB, have lower cardiovascular risk than those with low LDL but high ApoB.

ApoB is especially useful because it catches people who would be missed by focusing on cholesterol alone. If you have elevated triglycerides, your blood is likely full of small, atherogenic VLDL particles, even if your LDL cholesterol looks fine. Your ApoB would be high, and this would tell you the truth. Your standard lipid panel would miss it completely.

Many forward-thinking cardiologists now use ApoB as their primary target, not LDL cholesterol. This single shift in thinking would change how millions of people are managed.

Lp(a): the genetic time bomb you probably haven't heard of

Lipoprotein(a), or Lp(a), is a LDL-like particle with an additional protein called apolipoprotein(a) attached. It's almost entirely genetically determined, meaning if your parents had high Lp(a), you probably do too. And unlike LDL cholesterol, which you can change with diet and drugs, Lp(a) is remarkably resistant to most interventions.

Elevated Lp(a) independently increases heart disease risk, particularly for premature heart attacks. A major 2010 review in The Lancet demonstrated that elevated Lp(a) increases cardiovascular risk by about 30-50% per 50 mg/dL increase. That's substantial. And it affects roughly 20% of the population with elevated levels.

Here's what makes it clinically important: there's no standard drug treatment for Lp(a). Statins don't lower it. Neither do the newest PCSK9 inhibitors. Some PCSK9 inhibitors reduce it slightly, maybe 15-25%, but it's not reliable. This isn't a "lower Lp(a) with a pill" situation. Your only real interventions are lifestyle: no smoking (smoking increases Lp(a) particles), niacin supplementation (sometimes modest effects), possibly SGLT2 inhibitors in specific contexts, and aggressive management of all other risk factors since Lp(a) amplifies their effects.

Yet most people have never been tested for Lp(a). Most lipid panels don't include it. Many doctors don't think about it. If you have a family history of early heart disease, you absolutely should know your Lp(a) level. It changes how you manage everything else.

Triglycerides and the ratio that actually matters

Your triglyceride level is the amount of fat circulating in your blood. High triglycerides independently predict heart disease risk, but they also tell you something important: they're a marker of how many small, atherogenic VLDL particles you have.

But there's an even better marker: your triglyceride to HDL ratio. Divide your triglycerides by your HDL cholesterol. A ratio of less than 2 is considered protective. A ratio above 4 is concerning. This ratio captures something that individual numbers miss: it reflects the balance between atherogenic particles (reflected in triglycerides) and your protective particles (HDL).

Research shows that the triglyceride to HDL ratio is a surprisingly good predictor of insulin resistance, which drives many of the metabolic problems that lead to heart disease and diabetes. If your ratio is high, your metabolism isn't working properly, even if your total cholesterol looks fine.

Inflammation markers: the risk factor hiding in plain sight

You can have perfect cholesterol numbers and still have high heart disease risk. You can have high cholesterol and be at low risk. The missing piece is inflammation.

Chronic inflammation in your arterial walls is what actually drives atherosclerosis. Cholesterol particles deposit in the wall, your immune system perceives them as a threat, inflammation develops, plaques form. Without the inflammation component, cholesterol accumulation in the wall doesn't cause disease.

High-sensitivity C-reactive protein (hsCRP) is a simple marker of systemic inflammation. Studies consistently show that people with elevated hsCRP have higher cardiovascular risk, independent of their cholesterol levels. The Women's Health Study found that hsCRP predicted future heart attack better than LDL cholesterol in women. In fact, women with low LDL but high hsCRP had similar risk to those with high LDL but low hsCRP.

Other inflammation markers worth measuring include lipoprotein-associated phospholipase A2 (Lp-PLA2) and interleukin-6, though these are less commonly measured in standard practice.

The dietary cholesterol myth that won't die

You've heard it: dietary cholesterol raises your blood cholesterol. Cut eggs, cut butter, cut full-fat dairy. This advice has damaged people's health by pushing them toward processed foods and away from nutrient-dense whole foods.

The truth: dietary cholesterol has minimal impact on blood cholesterol for most people. Yes, there are some individuals who are "hyper-responders" where dietary cholesterol moves the needle. But for the majority, blood cholesterol is driven far more by refined carbohydrates, sugar, seed oils, and inflammatory processed foods than by dietary cholesterol itself.

Your liver produces about 80% of your blood cholesterol based on what your body needs. The 20% or so that comes from diet is largely inconsequential in the grand scheme. A 2015 meta-analysis in Nutrients found minimal relationship between dietary cholesterol intake and serum cholesterol levels in most people. The studies that did find effects often used extreme intakes or populations with specific genetic factors.

Far more important than dietary cholesterol is what you're not eating when you avoid cholesterol-rich foods. If avoiding eggs means you eat refined cereal, you've made your health worse. The foods highest in cholesterol (eggs, full-fat dairy, red meat) are also nutrient-dense and anti-inflammatory when they're from quality sources.

The statin debate: evidence, evidence, and more evidence

Statins lower LDL cholesterol, sometimes dramatically. They prevent heart attacks and strokes in certain populations. They also come with side effects that most people aren't told about.

For secondary prevention (people who have already had a heart attack or stroke), the evidence is strong. Statins reduce events and improve outcomes. In that context, for most people, the benefit outweighs risks.

For primary prevention (people with no history of heart disease), the picture is murkier. Statins reduce LDL, but the reduction in actual heart attacks and strokes is smaller and depends heavily on your baseline risk. For low-risk people, you might treat hundreds of people with statins for years to prevent a single heart event. The absolute benefit is tiny, even if the relative risk reduction looks impressive.

Add in side effects. Muscle pain, weakness, and statin-induced myopathy affect 5-20% of people taking statins, depending on dose and statin type. Many people experience subtle cognitive issues, fatigue, or sexual dysfunction they don't connect to their statin. Statins deplete CoQ10, which is important for mitochondrial function and muscle energy, which might explain the muscle-related side effects. For some people, these side effects severely impact quality of life.

There are also long-term concerns about statin use and cognitive decline, diabetes risk, and other metabolic effects, though research here is mixed and contested.

For primary prevention, the honest answer is: it depends on your actual risk profile. If you have multiple risk factors, elevated inflammation, elevated ApoB, positive family history, and are older, statins probably make sense. If you're young, metabolically healthy, with good inflammatory markers and normal ApoB, statins might not be worth it. The conversation should be personalised, not based on a single number.

Mediterranean diet: the one dietary pattern with real evidence

If you're concerned about heart health, forget about counting cholesterol in your diet. Focus instead on dietary patterns that lower inflammation, improve your lipid composition, and support metabolic health.

The Mediterranean diet has more evidence for cardiovascular protection than any other dietary pattern. The PREDIMED trial, a large randomised controlled study, showed that people following a Mediterranean diet had a 30% reduction in cardiovascular events compared to a control diet. That's massive. And it worked through multiple mechanisms: lower inflammation, improved lipid composition, better blood sugar control, reduced blood pressure.

The pattern includes: olive oil as the primary fat source, abundant vegetables and fruits, moderate fish consumption, moderate dairy (mostly cheese and yoghurt), limited red meat, and red wine in moderation, and fermented foods. Notably, eggs and poultry are regular parts of the diet. It's not about avoiding cholesterol, it's about choosing whole foods and anti-inflammatory fat sources.

What blood tests you actually need

Stop getting basic lipid panels and thinking you know your risk. Here's what you actually need to request from your GP or get through a private lab.

Standard lipid panel: total cholesterol, LDL, HDL, triglycerides. Baseline, but incomplete. Add: ApoB (measures actual atherogenic particle number), Lp(a) (genetic risk, especially if family history of early heart disease), high-sensitivity CRP (inflammation). Add metabolic markers: fasting glucose, HbA1c (blood sugar control), fasting insulin (insulin sensitivity). A simple lipid panel costs a few pounds but misses the picture. Adding these markers costs perhaps 30-50 pounds more and transforms what you actually know about your risk.

If your doctor won't order these tests, most private labs will. Thriva, LetsGetChecked, and others offer comprehensive lipid and metabolic panels directly. The information is too important to skip just because a test costs slightly more.

You have one cardiovascular system and one chance to protect it properly. The information deserves to be accurate.